NCBiotech Company Directory

A comprehensive listing of North Carolina's life science industry

Company Directory Search

Cellectis

Cellectis

Cellectis develops gene-editing technologies and cell therapies to treat cancers of the blood, myeloid, and lymphatic systems. The Raleigh location is the company's GMP manufacturing plant for Cellectis' portfolio of UCART drug products.

Company Location

2500 Sumner Blvd.

Raleigh
NC
27616
County
Region

Company Details

Year founded
1999
Employment range in NC
US headquarters
North Carolina
Global headquarters
France
Primary site activity
All company activities
Products under development
Immunotherapies based on gene-edited allogeneic CAR T-cells: UCART22 (B-ALL); UCART123 (AML); UCART20x22 (NHL)